These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 30104471

  • 1. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
    Fedorova OV, Ishkaraeva VV, Grigorova YN, Reznik VA, Kolodkin NI, Zazerskaya IE, Zernetkina V, Agalakova NI, Tapilskaya NI, Adair CD, Lakatta EG, Bagrov AY.
    Int J Mol Sci; 2018 Aug 13; 19(8):. PubMed ID: 30104471
    [Abstract] [Full Text] [Related]

  • 2. Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia.
    Agalakova NI, Grigorova YN, Ershov IA, Reznik VA, Mikhailova EV, Nadei OV, Samuilovskaya L, Romanova LA, Adair CD, Romanova IV, Bagrov AY.
    Int J Mol Sci; 2022 Mar 19; 23(6):. PubMed ID: 35328757
    [Abstract] [Full Text] [Related]

  • 3. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia.
    Agalakova NI, Reznik VA, Nadei OV, Ershov IA, Rassokha OS, Vasyutina ML, Ivanov DO, Adair CD, Galagudza MM, Bagrov AY.
    Am J Hypertens; 2020 May 21; 33(6):514-519. PubMed ID: 31713584
    [Abstract] [Full Text] [Related]

  • 4. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
    Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY.
    Cell Mol Biol (Noisy-le-grand); 2006 Dec 30; 52(8):19-23. PubMed ID: 17535731
    [Abstract] [Full Text] [Related]

  • 5. DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.
    Ishkaraeva-Yakovleva VV, Fedorova OV, Solodovnikova NG, Frolova EV, Bzhelyansky AM, Emelyanov IV, Adair CD, Zazerskaya IE, Bagrov AY.
    Reprod Sci; 2012 Dec 30; 19(12):1260-7. PubMed ID: 22649120
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky A, Reznik VA, Frolova EV, Nikitina ER, Budny GV, Longo DL, Lakatta EG, Bagrov AY.
    J Hypertens; 2008 Dec 30; 26(12):2414-25. PubMed ID: 19008721
    [Abstract] [Full Text] [Related]

  • 7. In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries.
    Nikitina ER, Mikhailov AV, Nikandrova ES, Frolova EV, Fadeev AV, Shman VV, Shilova VY, Tapilskaya NI, Shapiro JI, Fedorova OV, Bagrov AY.
    J Hypertens; 2011 Apr 30; 29(4):769-76. PubMed ID: 21330936
    [Abstract] [Full Text] [Related]

  • 8. Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.
    Zazerskaya IE, Ishkaraeva VV, Frolova EV, Solodovnikova NG, Grigorova YN, David Adair C, Fedorova OV, Bagrov AY.
    Am J Hypertens; 2013 Nov 30; 26(11):1269-72. PubMed ID: 23878005
    [Abstract] [Full Text] [Related]

  • 9. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY.
    J Hypertens; 1999 Aug 30; 17(8):1179-87. PubMed ID: 10466474
    [Abstract] [Full Text] [Related]

  • 10. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.
    Fedorova OV, Tapilskaya NI, Bzhelyansky AM, Frolova EV, Nikitina ER, Reznik VA, Kashkin VA, Bagrov AY.
    J Hypertens; 2010 Feb 30; 28(2):361-6. PubMed ID: 19927009
    [Abstract] [Full Text] [Related]

  • 11. Endogenous cardiotonic steroids in chronic renal failure.
    Kolmakova EV, Haller ST, Kennedy DJ, Isachkina AN, Budny GV, Frolova EV, Piecha G, Nikitina ER, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY.
    Nephrol Dial Transplant; 2011 Sep 30; 26(9):2912-9. PubMed ID: 21292813
    [Abstract] [Full Text] [Related]

  • 12. Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats.
    Grigorova YN, Wei W, Petrashevskaya N, Zernetkina V, Juhasz O, Fenner R, Gilbert C, Lakatta EG, Shapiro JI, Bagrov AY, Fedorova OV.
    Int J Mol Sci; 2018 Oct 15; 19(10):. PubMed ID: 30326586
    [Abstract] [Full Text] [Related]

  • 13. Silencing of Fli1 Gene Mimics Effects of Preeclampsia and Induces Collagen Synthesis in Human Umbilical Arteries.
    Agalakova NI, Reznik VA, Ershov IA, Lupanova EA, Nadei OV, Ivanov DO, David Adair C, Bagrov AY.
    Am J Hypertens; 2022 Sep 01; 35(9):828-832. PubMed ID: 35569064
    [Abstract] [Full Text] [Related]

  • 14. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
    Fedorova OV, Emelianov IV, Bagrov KA, Grigorova YN, Wei W, Juhasz O, Frolova EV, Marshall CA, Lakatta EG, Konradi AO, Bagrov AY.
    J Hypertens; 2015 Aug 01; 33(8):1602-10. PubMed ID: 26136067
    [Abstract] [Full Text] [Related]

  • 15. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake.
    Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG, Bagrov AY.
    J Hypertens; 2005 Apr 01; 23(4):835-42. PubMed ID: 15775789
    [Abstract] [Full Text] [Related]

  • 16. Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, is Reduced by a Monoclonal Antibody to Marinobufagenin.
    Grigorova YN, Juhasz O, Zernetkina V, Fishbein KW, Lakatta EG, Fedorova OV, Bagrov AY.
    Am J Hypertens; 2016 May 01; 29(5):641-6. PubMed ID: 26350300
    [Abstract] [Full Text] [Related]

  • 17. Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis.
    Agalakova NI, Kolodkin NI, Adair CD, Trashkov AP, Bagrov AY.
    Int J Mol Sci; 2021 Feb 16; 22(4):. PubMed ID: 33669287
    [Abstract] [Full Text] [Related]

  • 18. Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.
    Fedorova OV, Fadeev AV, Grigorova YN, Marshall CA, Zernetkina V, Kolodkin NI, Agalakova NI, Konradi AO, Lakatta EG, Bagrov AY.
    J Cardiovasc Pharmacol; 2019 Nov 16; 74(5):436-442. PubMed ID: 31415452
    [Abstract] [Full Text] [Related]

  • 19. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT.
    J Hypertens; 2000 Feb 16; 18(2):209-15. PubMed ID: 10694190
    [Abstract] [Full Text] [Related]

  • 20. Involvement of marinobufagenin in a rat model of human preeclampsia.
    Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, Puschett JB.
    Am J Nephrol; 2005 Feb 16; 25(5):520-8. PubMed ID: 16179779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.